Track topics on Twitter Track topics that are important to you
There are serious doubts about Spark Therapeutics’ haemophilia A gene therapy after two out of seven patients on a high dose in an early-stage trial suffered a serious immune response. The news of a safety concern with the treatment sent the compa...
Original Article: Spark shares tank after haemophilia gene therapy safety signalNEXT ARTICLE
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...